Results from the current study again confirm this hypothesis in that DTT, an S-nitrosylation pathway inhibitor but not ODQ, an NO/sGC/cGMP pathway inhibitor, caused arrhythmias in 100% of the treated embryonic zebrafish population. This evidence concerns the gene SGCB and cardiac arrhythmia.